Childhood arthritis

Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors

Retrieved on: 
Thursday, February 22, 2024

Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors

Key Points: 
  • Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
    Paris, February 22, 2024.
  • The Chairman warmly thanked them for their valued contribution to the Board of Directors and the specialized committees to which they belonged during their terms in office.
  • In 2016, Clotilde Delbos was appointed Group Chief Financial Officer and Chairman of Board of Directors of RCI Banque.
  • “The arrivals of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy will strengthen the Board of Directors’ expertise in finance and science, notably in the field of immunology.

BioTek reMEDys Calls for Increased Juvenile Arthritis Awareness and Education

Retrieved on: 
Wednesday, July 19, 2023

With July being Juvenile Arthritis Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.

Key Points: 
  • With July being Juvenile Arthritis Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.
  • An estimated 300,000 children in the US are affected by some form of Juvenile Arthritis (JA).
  • BioTek reMEDys is urging its clinical and patient constituents and the population at large to become more aware and get involved via national resources such as the Arthritis Foundation .
  • To draw awareness to the condition, BioTek reMEDys is also encouraging people to share their stories online or via social media with the hashtag #StrongerThanJA.

Cassie + Friends and Brain Canada Announce a New Research Partnership to Transform the Mental Health of Youth with Pediatric Rheumatic Disease

Retrieved on: 
Sunday, May 7, 2023

Pediatric rheumatic diseases can have long-term physical and psychosocial effects on a young person.

Key Points: 
  • Pediatric rheumatic diseases can have long-term physical and psychosocial effects on a young person.
  • Jennifer Wilson, Executive Director of Cassie + Friends, says: “Children growing up with rheumatic disease can be severely affected by their diagnosis, symptoms, and treatments.
  • "We are proud to partner with Cassie + Friends to support this important research initiative," says Dr. Viviane Poupon, President, and CEO of Brain Canada.
  • For more information about the program and how to apply, please subscribe to receive funding opportunities from Brain Canada: LINK

CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE ANNOUNCES MATHIEU NELESSEN AS NEW CEO

Retrieved on: 
Tuesday, December 6, 2022

WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- The Childhood Arthritis and Rheumatology Research Alliance, also known as CARRA, announced the appointment of Mathieu Nelessen as Chief Executive Officer, effective January 9, 2023.

Key Points: 
  • WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- The Childhood Arthritis and Rheumatology Research Alliance, also known as CARRA, announced the appointment of Mathieu Nelessen as Chief Executive Officer, effective January 9, 2023.
  • The CARRA Board of Directors unanimously approved the recommendation of Mr. Nelessen by a CARRA CEO search task force, which led a three-month nationwide search.
  • "We welcome Mathieu to the country's foremost network of pediatric rheumatologists," said CARRA President Robert Colbert, MD, PhD.
  • Childhood-onset rheumatic diseases include different types of arthritis and other rheumatic and inflammatory diseases that develop in children and teens.

Researchers Find Lower Risk of Severe COVID-19 Infection in Most Children with Juvenile Idiopathic Arthritis

Retrieved on: 
Thursday, March 31, 2022

The findings, published in the Annals of the Rheumatic Diseases , involved reports on patients from investigators across 25 countries.

Key Points: 
  • The findings, published in the Annals of the Rheumatic Diseases , involved reports on patients from investigators across 25 countries.
  • The Arthritis Foundation estimates there are nearly 300,000 children and teens with arthritis in the United States.
  • Researchers found that less than 10% of pediatric patients with rheumatic diseases who were diagnosed with COVID-19 required hospitalization.
  • Childhood-onset rheumatic diseases include different types of arthritis and other rheumatic and inflammatory diseases that develop in children and teens.

Global Musculoskeletal Partnering Deal Trends, Players and Financials Analysis Report 2021: Analyse Deals Entered into by the World's Leading Life Science Companies Since 2014 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 20, 2022

The "Global Musculoskeletal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Musculoskeletal Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Musculoskeletal Partnering 2014-2021 report provides comprehensive access to available deals and contract documents for over 600 musculoskeletal deals.
  • The report takes readers through the comprehensive Musculoskeletal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Musculoskeletal deals.
  • The report also includes numerous tables and figures that illustrate the trends and activities in Musculoskeletal partnering and dealmaking since 2014.

Arthritis National Research Foundation Awards 18 New Research Grants

Retrieved on: 
Thursday, May 6, 2021

b'The Arthritis National Research Foundation (ANRF) is proud to announce the awarding of 18 new research grants to scientists across the U.S. with bold new ideas for the treatment of arthritis and related autoimmune conditions.

Key Points: 
  • b'The Arthritis National Research Foundation (ANRF) is proud to announce the awarding of 18 new research grants to scientists across the U.S. with bold new ideas for the treatment of arthritis and related autoimmune conditions.
  • Ultimately, they selected 18 projects that could represent the future of diagnostics and treatments across the spectrum of autoimmune diseases.
  • These include Rheumatoid Arthritis, Juvenile Arthritis, Spondylarthritis, Osteoarthritis, Lupus, Scleroderma, and infection-induced autoimmunity in COVID-19 patients.
  • This commitment is shared by our community of individual supporters and bolstered by new industry partnerships.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210506005200/en/\n'

Children with Arthritis Living in Less Affluent Families More Likely to Report Longer Duration of Morning Joint Stiffness

Retrieved on: 
Saturday, November 7, 2020

Juvenile idiopathic arthritis (JIA) is a condition involving joint inflammation that lasts more than six weeks in children or adolescents under 16 years of age.

Key Points: 
  • Juvenile idiopathic arthritis (JIA) is a condition involving joint inflammation that lasts more than six weeks in children or adolescents under 16 years of age.
  • It is the most common form of childhood arthritis, affecting about 1 in 1,000 children and teens in the United States.
  • "Reported morning joint stiffness may be a better indicator of early disease symptoms than pain since reporting pain can be influenced by cultural factors.
  • The investigators extracted data on the presence and duration of morning joint stiffness.

Westwind Integrated Health Raises Awareness of Juvenile Arthritis in Phoenix, AZ, and Its Effects on Oral and Overall Health

Retrieved on: 
Tuesday, May 5, 2020

PHOENIX, May 5, 2020 /PRNewswire-PRWeb/ --Westwind Integrated Health is spreading awareness of juvenile arthritis and how it affects nearly 300,000 children in the United States.

Key Points: 
  • PHOENIX, May 5, 2020 /PRNewswire-PRWeb/ --Westwind Integrated Health is spreading awareness of juvenile arthritis and how it affects nearly 300,000 children in the United States.
  • Westwind Integrated Health specializes in both dental and medical treatment, so children suffering from juvenile arthritis in Phoenix, AZ can receive comprehensive pediatric care from this versatile practice.
  • Common causes and symptoms of juvenile arthritis include:
    Children with juvenile arthritis are more at risk of inflamed gum tissue and of being diagnosed with gum disease.
  • The doctors at Westwind Integrated Health advise parents to not let their children neglect their oral health and to schedule dental exams every six months.

The ACR and the Arthritis Foundation Present New Guidelines Offering Therapeutic Approaches and Treatment Options for Juvenile Idiopathic Arthritis

Retrieved on: 
Monday, April 29, 2019

ATLANTA, April 29, 2019 /PRNewswire/ --Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA) .

Key Points: 
  • ATLANTA, April 29, 2019 /PRNewswire/ --Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA) .
  • One guideline aims to provide therapeutic approaches for non-systemic polyarthritis, sacroilitis and enthesitis; and the other focuses on the screening, monitoring and treatment of JIA with associated uveitis.
  • Juvenile arthritis (JA) is a common, chronic childhood disease that affects nearly 300,000 children in the United States.
  • Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases.